Core Laboratories N.V.CLBNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank14
3Y CAGR+15.3%
5Y CAGR-13.3%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+15.3%/yr
vs -36.4%/yr prior
5Y CAGR
-13.3%/yr
Recent acceleration
Acceleration
+51.7pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $22.59M | -47.9% |
| 2024 | $43.36M | +205.1% |
| 2023 | $14.21M | -3.6% |
| 2022 | $14.74M | -36.0% |
| 2021 | $23.04M | -49.9% |
| 2020 | $45.99M | -31.6% |
| 2019 | $67.26M | -25.3% |
| 2018 | $90.09M | -14.6% |
| 2017 | $105.50M | -12.2% |
| 2016 | $120.18M | - |